VALPROIC ACID

VALPROIC ACID was reported 31799 times

VALPROIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL DNA MUTATION 40 0.4651
1 PAROXYSMAL PERCEPTUAL ALTERATION 21 0.3500
2 NEW ONSET REFRACTORY STATUS EPILEPTICUS 31 0.2818
3 HYPERAMMONAEMIC ENCEPHALOPATHY 473 0.2718
4 INTRA-ABDOMINAL PRESSURE INCREASED 35 0.2229
5 CARNITINE DEFICIENCY 38 0.2222
6 FOETAL ANTICONVULSANT SYNDROME 218 0.1838
7 MULTIPLE-DRUG RESISTANCE 543 0.1749
8 CSF OLIGOCLONAL BAND PRESENT 21 0.1615
9 CONGENITAL NOSE MALFORMATION 77 0.1447
10 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 94 0.1446
11 EOSINOPHILIC PLEURAL EFFUSION 43 0.1443
12 POSTICTAL PSYCHOSIS 22 0.1410
13 DECREASED EYE CONTACT 39 0.1283
14 HYPERAMMONAEMIA 628 0.1254
15 RENAL FUSION ANOMALY 19 0.1210
16 NECROSIS ISCHAEMIC 54 0.1169
17 MYOCLONIC EPILEPSY 158 0.1041
18 SCHIZOAFFECTIVE DISORDER 184 0.1031
19 LENNOX-GASTAUT SYNDROME 22 0.0969
20 VASCULAR ENCEPHALOPATHY 27 0.0951
21 EPILEPTIC ENCEPHALOPATHY 21 0.0942
22 PROPOFOL INFUSION SYNDROME 65 0.0922
23 FAILURE TO SUSPEND MEDICATION 19 0.0918
24 CONGENITAL ORAL MALFORMATION 20 0.0913
25 NEOVASCULARISATION 24 0.0913
26 POSTICTAL PARALYSIS 22 0.0909
27 SINUS RHYTHM 38 0.0874
28 OPPOSITIONAL DEFIANT DISORDER 34 0.0861
29 SKULL MALFORMATION 54 0.0840
30 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 39 0.0833
31 WITHDRAWAL CATATONIA 19 0.0823
32 OSCILLOPSIA 21 0.0811
33 DYSMORPHISM 190 0.0806
34 ACIDOSIS HYPERCHLORAEMIC 47 0.0791
35 CENTRAL SLEEP APNOEA SYNDROME 25 0.0769
36 PSYCHIATRIC DECOMPENSATION 142 0.0726
37 ANTICONVULSANT DRUG LEVEL INCREASED 113 0.0699
38 ATONIC SEIZURES 60 0.0698
39 SEIZURE CLUSTER 57 0.0688
40 VAGAL NERVE STIMULATOR IMPLANTATION 21 0.0686
41 POSTURAL TREMOR 20 0.0685
42 LOW SET EARS 28 0.0681
43 STATUS EPILEPTICUS 763 0.0675
44 PNEUMATOSIS 30 0.0674
45 PSYCHOGENIC SEIZURE 62 0.0663
46 PSYCHOMOTOR SKILLS IMPAIRED 172 0.0656
47 RESTING TREMOR 42 0.0650
48 MENINGOMYELOCELE 39 0.0650
49 EXPRESSIVE LANGUAGE DISORDER 18 0.0632
50 TONIC CONVULSION 88 0.0621
51 ASOCIAL BEHAVIOUR 20 0.0619
52 CONGENITAL FOOT MALFORMATION 28 0.0617
53 FANCONI SYNDROME 87 0.0615
54 CHANGE IN SEIZURE PRESENTATION 39 0.0603
55 ANTIPSYCHOTIC DRUG LEVEL DECREASED 32 0.0603
56 PLAGIOCEPHALY 30 0.0601
57 HYPERTELORISM OF ORBIT 25 0.0598
58 CHOREOATHETOSIS 40 0.0589
59 CEREBELLAR ATROPHY 51 0.0579
60 ANTICONVULSANT DRUG LEVEL DECREASED 81 0.0573
61 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 43 0.0571
62 DELUSION OF GRANDEUR 25 0.0557
63 INFANTILE SPASMS 40 0.0553
64 PETIT MAL EPILEPSY 279 0.0546
65 LIMB MALFORMATION 43 0.0544
66 SYNDACTYLY 45 0.0542
67 BLOOD GASES ABNORMAL 29 0.0538
68 HYPOSPADIAS 105 0.0504
69 MOTOR DEVELOPMENTAL DELAY 29 0.0502
70 EAR MALFORMATION 23 0.0497
71 FOCAL DYSCOGNITIVE SEIZURES 56 0.0492
72 DROP ATTACKS 29 0.0487
73 INTELLECTUAL DISABILITY 74 0.0487
74 DEVELOPMENTAL HIP DYSPLASIA 40 0.0481
75 AMMONIA INCREASED 232 0.0454
76 CRANIOSYNOSTOSIS 39 0.0450
77 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 24 0.0448
78 DRUG LEVEL CHANGED 28 0.0444
79 DYSPRAXIA 25 0.0443
80 NEUROLEPTIC MALIGNANT SYNDROME 520 0.0438
81 NEURODEVELOPMENTAL DISORDER 29 0.0429
82 CRYPTORCHISM 48 0.0427
83 DYSMETRIA 25 0.0414
84 SPINA BIFIDA 85 0.0408
85 PSYCHOMOTOR RETARDATION 113 0.0402
86 CATATONIA 211 0.0401
87 PLEOCYTOSIS 23 0.0395
88 CONGENITAL HAND MALFORMATION 27 0.0394
89 OCULOGYRIC CRISIS 83 0.0386
90 DRUG WITHDRAWAL CONVULSIONS 67 0.0376
91 PLEUROTHOTONUS 34 0.0376
92 CLONIC CONVULSION 27 0.0369
93 PARTIAL SEIZURES 193 0.0368
94 DRUG-DISEASE INTERACTION 27 0.0368
95 DEPRESSIVE SYMPTOM 129 0.0366
96 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 32 0.0359
97 SPEECH DISORDER DEVELOPMENTAL 101 0.0352
98 HYPERCHLORAEMIA 22 0.0344
99 ANTIPSYCHOTIC DRUG LEVEL INCREASED 96 0.0341
100 BEHAVIOUR DISORDER 180 0.0332
101 ELECTROENCEPHALOGRAM ABNORMAL 104 0.0329
102 ASTERIXIS 35 0.0329
103 ARNOLD-CHIARI MALFORMATION 31 0.0325
104 DEPRESSION SUICIDAL 111 0.0320
105 MICROCEPHALY 41 0.0320
106 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 22 0.0318
107 GAZE PALSY 53 0.0311
108 PARKINSONISM 300 0.0307
109 DRUG LEVEL INCREASED 504 0.0304
110 POLYDACTYLY 35 0.0302
111 HYPERNATRAEMIA 150 0.0301
112 PARADOXICAL DRUG REACTION 110 0.0299
113 COMPLEX PARTIAL SEIZURES 33 0.0297
114 LIP DISORDER 56 0.0295
115 PERSECUTORY DELUSION 73 0.0292
116 MITOCHONDRIAL TOXICITY 24 0.0292
117 GENERALISED TONIC-CLONIC SEIZURE 477 0.0288
118 TOXIC ENCEPHALOPATHY 146 0.0288
119 EXCESSIVE EYE BLINKING 42 0.0284
120 CEREBRAL ATROPHY 110 0.0276
121 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20 0.0267
122 STEREOTYPY 25 0.0265
123 TEARFULNESS 114 0.0265
124 TALIPES 82 0.0264
125 COGWHEEL RIGIDITY 27 0.0257
126 MULTIPLE DRUG THERAPY 19 0.0252
127 HYPERKINESIA 53 0.0250
128 STUPOR 80 0.0249
129 ATAXIA 292 0.0246
130 SUBILEUS 50 0.0240
131 DRUG LEVEL BELOW THERAPEUTIC 132 0.0239
132 NYSTAGMUS 126 0.0237
133 AUTISM 24 0.0236
134 THERAPEUTIC PRODUCT CROSS-REACTIVITY 21 0.0235
135 SIMPLE PARTIAL SEIZURES 19 0.0235
136 SALIVARY HYPERSECRETION 234 0.0234
137 GENE MUTATION 45 0.0227
138 DRUG INTERACTION 3570 0.0225
139 CLEFT LIP AND PALATE 25 0.0224
140 TONIC CLONIC MOVEMENTS 29 0.0223
141 PSYCHOTIC SYMPTOM 46 0.0223
142 CLEFT PALATE 43 0.0222
143 MEDICATION OVERUSE HEADACHE 19 0.0222
144 EPILEPSY 679 0.0222
145 FEBRILE CONVULSION 27 0.0221
146 IDIOSYNCRATIC DRUG REACTION 21 0.0214
147 PYLORIC STENOSIS 18 0.0213
148 ACCIDENTAL DEATH 39 0.0210
149 METABOLIC ENCEPHALOPATHY 63 0.0210
150 MUCOSAL ULCERATION 21 0.0209
151 MYOCLONUS 248 0.0208
152 GLYCOSURIA 28 0.0207
153 EOSINOPHIL COUNT DECREASED 49 0.0206
154 DISINHIBITION 33 0.0205
155 ASTIGMATISM 31 0.0204
156 GINGIVAL HYPERTROPHY 31 0.0204
157 BRUGADA SYNDROME 21 0.0203
158 MULTIPLE CONGENITAL ABNORMALITIES 29 0.0201
159 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 77 0.0201
160 FEEDING DISORDER NEONATAL 21 0.0201
161 QUADRIPARESIS 33 0.0199
162 HYPOTONIA NEONATAL 31 0.0198
163 INTESTINAL ISCHAEMIA 109 0.0198
164 HYPOMANIA 72 0.0196
165 CEREBRAL VENTRICLE DILATATION 22 0.0191
166 LEARNING DISORDER 45 0.0186
167 DRUG RESISTANCE 478 0.0186
168 MUTISM 27 0.0186
169 NEPHROCALCINOSIS 22 0.0185
170 POSTICTAL STATE 19 0.0183
171 NEPHROGENIC DIABETES INSIPIDUS 21 0.0182
172 SUBSTANCE USE 28 0.0179
173 VENTRICULAR SEPTAL DEFECT 101 0.0176
174 MYOCARDITIS 201 0.0175
175 HYPERTROPHIC CARDIOMYOPATHY 27 0.0174
176 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 29 0.0174
177 DISTRACTIBILITY 20 0.0173
178 MULTIPLE DRUG OVERDOSE 86 0.0173
179 SEIZURE 1978 0.0171
180 WRONG PATIENT RECEIVED PRODUCT 50 0.0171
181 SEDATION 445 0.0170
182 ENCEPHALITIS AUTOIMMUNE 22 0.0167
183 HYPOTHERMIA 169 0.0167
184 PSYCHOTIC DISORDER 487 0.0165
185 BIPOLAR I DISORDER 36 0.0164
186 MONOCYTE COUNT DECREASED 20 0.0164
187 PROCALCITONIN INCREASED 19 0.0162
188 ILEUS PARALYTIC 71 0.0159
189 COMPLETED SUICIDE 1311 0.0157
190 MUSCLE RIGIDITY 188 0.0157
191 ANTICHOLINERGIC SYNDROME 25 0.0157
192 LIP HAEMORRHAGE 20 0.0157
193 SEDATION COMPLICATION 40 0.0157
194 CHOREA 27 0.0157
195 PUPILLARY REFLEX IMPAIRED 29 0.0157
196 HYPERLACTACIDAEMIA 42 0.0156
197 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 35 0.0156
198 EDUCATIONAL PROBLEM 26 0.0156
199 RENAL TUBULAR ACIDOSIS 34 0.0156
200 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50 0.0154
201 POSTURE ABNORMAL 50 0.0154
202 SCHIZOPHRENIA 186 0.0153
203 LANGUAGE DISORDER 33 0.0153
204 AUTISM SPECTRUM DISORDER 84 0.0152
205 DEVELOPMENTAL DELAY 136 0.0151
206 ENCEPHALOPATHY 370 0.0151
207 NECROTISING COLITIS 19 0.0150
208 SUPERINFECTION 22 0.0147
209 DRUG LEVEL DECREASED 149 0.0146
210 DIABETES INSIPIDUS 35 0.0145
211 BLOOD LACTIC ACID INCREASED 76 0.0144
212 GRAND MAL CONVULSION 133 0.0144
213 PATENT DUCTUS ARTERIOSUS 57 0.0143
214 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 38 0.0143
215 IMPULSIVE BEHAVIOUR 53 0.0141
216 SUSPECTED SUICIDE 66 0.0141
217 BLOOD PH DECREASED 24 0.0140
218 RESPIRATORY ACIDOSIS 55 0.0140
219 HYPOTONIA 139 0.0139
220 DEPRESSED LEVEL OF CONSCIOUSNESS 543 0.0137
221 AGGRESSION 684 0.0137
222 MANIA 221 0.0134
223 HAEMANGIOMA 31 0.0134
224 BRADYPNOEA 36 0.0133
225 ILLUSION 22 0.0133
226 CEREBELLAR SYNDROME 29 0.0132
227 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 340 0.0132
228 PSYCHOMOTOR HYPERACTIVITY 217 0.0131
229 HOMICIDAL IDEATION 53 0.0131
230 HYPOREFLEXIA 25 0.0130
231 ATRIAL SEPTAL DEFECT 109 0.0130
232 POISONING 162 0.0129
233 ELECTROCARDIOGRAM QT PROLONGED 462 0.0128
234 APRAXIA 19 0.0128
235 PUPIL FIXED 22 0.0127
236 MATERNAL DRUGS AFFECTING FOETUS 97 0.0126
237 INHIBITORY DRUG INTERACTION 20 0.0126
238 NEUROLOGICAL DECOMPENSATION 29 0.0125
239 CLONUS 34 0.0124
240 STARING 30 0.0124
241 HYPERTONIA 71 0.0124
242 TORTICOLLIS 26 0.0123
243 EXTRAPYRAMIDAL DISORDER 303 0.0122
244 RESPIRATORY DEPRESSION 148 0.0121
245 TOXIC EPIDERMAL NECROLYSIS 183 0.0120
246 TOXICITY TO VARIOUS AGENTS 2024 0.0120
247 FANCONI SYNDROME ACQUIRED 21 0.0120
248 STILLBIRTH 57 0.0118
249 PANCREATITIS NECROTISING 27 0.0117
250 PNEUMONIA PSEUDOMONAL 18 0.0117
251 BRAIN OEDEMA 147 0.0116
252 HYPERREFLEXIA 40 0.0115
253 FOETAL EXPOSURE DURING PREGNANCY 931 0.0114
254 PARANOIA 197 0.0114
255 MENTAL STATUS CHANGES 317 0.0114
256 DELIRIUM 395 0.0114
257 BRAIN DEATH 35 0.0113
258 PNEUMONIA ASPIRATION 282 0.0113
259 COMA 537 0.0113
260 MULTIPLE DRUG OVERDOSE INTENTIONAL 36 0.0112
261 BRADYKINESIA 66 0.0112
262 METABOLIC ACIDOSIS 355 0.0111
263 DRUG TOXICITY 151 0.0111
264 HYPOVENTILATION 36 0.0110
265 PRIAPISM 38 0.0110
266 METABOLIC SYNDROME 18 0.0109
267 STEVENS-JOHNSON SYNDROME 242 0.0109
268 DISORGANISED SPEECH 20 0.0108
269 ALTERED STATE OF CONSCIOUSNESS 234 0.0108
270 ACUTE HEPATIC FAILURE 147 0.0107
271 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 55 0.0107
272 COMA SCALE ABNORMAL 31 0.0107
273 AUTONOMIC NERVOUS SYSTEM IMBALANCE 31 0.0106
274 BLOOD BICARBONATE DECREASED 20 0.0106
275 LOGORRHOEA 37 0.0105
276 BLOOD CREATINE PHOSPHOKINASE INCREASED 298 0.0103
277 HALLUCINATION, AUDITORY 164 0.0103
278 ANAEMIA MACROCYTIC 22 0.0103
279 HYPERCAPNIA 31 0.0103
280 HYPERTHERMIA 78 0.0102
281 STRABISMUS 30 0.0102
282 DISTURBANCE IN SOCIAL BEHAVIOUR 24 0.0102
283 DRUG LEVEL ABOVE THERAPEUTIC 46 0.0100
284 GASTROINTESTINAL NECROSIS 29 0.0099
285 HAEMODYNAMIC INSTABILITY 75 0.0098
286 COMMUNICATION DISORDER 37 0.0097
287 AKATHISIA 132 0.0097
288 AKINESIA 20 0.0096
289 ENURESIS 39 0.0096
290 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 99 0.0096
291 BLOOD SODIUM INCREASED 26 0.0096
292 ABNORMAL BEHAVIOUR 380 0.0096
293 SEROTONIN SYNDROME 183 0.0095
294 MOTOR DYSFUNCTION 97 0.0095
295 COGNITIVE DISORDER 438 0.0094
296 HEART DISEASE CONGENITAL 33 0.0093
297 COORDINATION ABNORMAL 130 0.0093
298 ACUTE PSYCHOSIS 23 0.0093
299 DYSARTHRIA 350 0.0093
300 LEUKOCYTOSIS 168 0.0093
301 AFFECT LABILITY 88 0.0091
302 HYPERACUSIS 34 0.0091
303 CELL DEATH 18 0.0091
304 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 80 0.0090
305 BRAIN HERNIATION 27 0.0090
306 CONVULSION 515 0.0090
307 DELUSION 138 0.0089
308 POLYDIPSIA 35 0.0088
309 AFFECTIVE DISORDER 69 0.0088
310 FAECALOMA 48 0.0088
311 ABDOMINAL TENDERNESS 43 0.0087
312 RASH MORBILLIFORM 24 0.0086
313 AGITATION 635 0.0086
314 INTENTIONAL OVERDOSE 548 0.0085
315 PANCREATITIS ACUTE 191 0.0085
316 HYPERPROLACTINAEMIA 55 0.0085
317 NEONATAL RESPIRATORY DISTRESS SYNDROME 30 0.0085
318 SUICIDAL BEHAVIOUR 35 0.0084
319 BRUXISM 45 0.0083
320 MONOCYTE COUNT INCREASED 30 0.0083
321 DROOLING 57 0.0082
322 AREFLEXIA 22 0.0082
323 NEUTROPHIL COUNT INCREASED 84 0.0082
324 BIPOLAR DISORDER 89 0.0082
325 RENAL TUBULAR DISORDER 23 0.0082
326 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 78 0.0082
327 SOPOR 108 0.0081
328 MEDICATION RESIDUE 21 0.0081
329 DYSTONIA 158 0.0081
330 ACIDOSIS 62 0.0081
331 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 21 0.0080
332 VENTRICULAR ARRHYTHMIA 29 0.0079
333 HEPATOTOXICITY 175 0.0079
334 CONJUNCTIVAL HYPERAEMIA 28 0.0078
335 ATTENTION DEFICIT HYPERACTIVITY DISORDER 33 0.0078
336 CARDIO-RESPIRATORY ARREST 325 0.0078
337 EOSINOPHILIA 135 0.0077
338 RED CELL DISTRIBUTION WIDTH INCREASED 32 0.0077
339 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
340 UNRESPONSIVE TO STIMULI 198 0.0077
341 THERAPY PARTIAL RESPONDER 119 0.0076
342 PSYCHIATRIC SYMPTOM 56 0.0076
343 MYOPIA 18 0.0076
344 TRISMUS 39 0.0075
345 PRESCRIBED OVERDOSE 146 0.0075
346 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 413 0.0075
347 POISONING DELIBERATE 70 0.0074
348 RHABDOMYOLYSIS 307 0.0074
349 BRADYPHRENIA 48 0.0073
350 COAGULOPATHY 122 0.0073
351 APNOEA 57 0.0073
352 RESPIRATORY ARREST 201 0.0073
353 OTITIS MEDIA 24 0.0073
354 SINUS TACHYCARDIA 103 0.0072
355 LEFT VENTRICULAR HYPERTROPHY 31 0.0072
356 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 56 0.0072
357 MIOSIS 57 0.0071
358 SUICIDE ATTEMPT 430 0.0071
359 HYPERTRANSAMINASAEMIA 49 0.0070
360 GRANULOCYTOPENIA 40 0.0070
361 DISORIENTATION 278 0.0070
362 LEARNING DISABILITY 37 0.0069
363 ENCEPHALITIS 48 0.0069
364 TREATMENT NONCOMPLIANCE 378 0.0069
365 HEPATIC FAILURE 208 0.0069
366 METABOLIC DISORDER 40 0.0069
367 GASTROINTESTINAL SOUNDS ABNORMAL 34 0.0069
368 POTENTIATING DRUG INTERACTION 23 0.0068
369 RESPIRATORY RATE DECREASED 21 0.0067
370 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 317 0.0066
371 BLOOD PHOSPHORUS INCREASED 18 0.0066
372 BLOOD PROLACTIN INCREASED 31 0.0066
373 LYMPHOCYTE COUNT INCREASED 21 0.0064
374 SOMNOLENCE 1293 0.0064
375 HALLUCINATIONS, MIXED 27 0.0064
376 DYSGRAPHIA 42 0.0064
377 HYPOPNOEA 22 0.0063
378 DYSPHORIA 32 0.0063
379 TROPONIN INCREASED 48 0.0063
380 THERAPEUTIC AGENT TOXICITY 21 0.0063
381 REBOUND EFFECT 71 0.0063
382 SHOCK 144 0.0063
383 APATHY 91 0.0062
384 INTENTIONAL SELF-INJURY 126 0.0062
385 SOCIAL AVOIDANT BEHAVIOUR 36 0.0062
386 MENTAL IMPAIRMENT 150 0.0062
387 MYDRIASIS 79 0.0062
388 SUDDEN DEATH 65 0.0061
389 BUNDLE BRANCH BLOCK RIGHT 28 0.0061
390 FOOT DEFORMITY 67 0.0060
391 HYPERVENTILATION 35 0.0060
392 RASH MACULO-PAPULAR 134 0.0060
393 TACHYPNOEA 81 0.0060
394 STREPTOCOCCAL INFECTION 33 0.0059
395 FIBRIN D DIMER INCREASED 21 0.0059
396 TREATMENT FAILURE 486 0.0059
397 EUPHORIC MOOD 60 0.0059
398 HYPERTRIGLYCERIDAEMIA 34 0.0058
399 TRANSAMINASES INCREASED 129 0.0058
400 HYPOALBUMINAEMIA 45 0.0058
401 IRRITABILITY 348 0.0058
402 NEUROLOGICAL SYMPTOM 33 0.0058
403 ASPIRATION 63 0.0057
404 THROMBOCYTOPENIA 642 0.0057
405 TORSADE DE POINTES 45 0.0057
406 CARDIOMEGALY 70 0.0057
407 HYDROCEPHALUS 31 0.0057
408 DYSKINESIA 231 0.0057
409 HEPATITIS CHOLESTATIC 34 0.0056
410 ILEUS 70 0.0056
411 MAJOR DEPRESSION 41 0.0056
412 HYPOCALCAEMIA 106 0.0056
413 RESTLESSNESS 203 0.0055
414 DRUG-INDUCED LIVER INJURY 174 0.0055
415 LEUKOPENIA 276 0.0055
416 REFUSAL OF TREATMENT BY PATIENT 36 0.0055
417 HEPATOMEGALY 54 0.0055
418 SPEECH DISORDER 287 0.0055
419 NEUTROPHILIA 31 0.0054
420 BLOOD ALBUMIN DECREASED 43 0.0054
421 INCOHERENT 35 0.0054
422 DEPRESSION 1230 0.0054
423 DRUG EXPOSURE DURING PREGNANCY 182 0.0053
424 ABORTION SPONTANEOUS 214 0.0053
425 SCREAMING 34 0.0053
426 WRONG PRODUCT ADMINISTERED 36 0.0053
427 HYPONATRAEMIA 300 0.0053
428 SCOLIOSIS 33 0.0053
429 DYSLIPIDAEMIA 27 0.0053
430 TYPE 1 DIABETES MELLITUS 32 0.0053
431 HALLUCINATION, VISUAL 112 0.0053
432 BLOOD THYROID STIMULATING HORMONE DECREASED 24 0.0053
433 EYE MOVEMENT DISORDER 36 0.0053
434 APLASIA PURE RED CELL 18 0.0052
435 PERIORBITAL OEDEMA 27 0.0052
436 PRODUCT PREPARATION ISSUE 34 0.0052
437 HYPOKINESIA 75 0.0052
438 CARDIAC ARREST 425 0.0051
439 HYPOPHOSPHATAEMIA 38 0.0051
440 RHINOVIRUS INFECTION 20 0.0051
441 OBESITY 81 0.0051
442 AGRANULOCYTOSIS 94 0.0051
443 CONGENITAL ANOMALY 39 0.0050
444 HEPATIC ENCEPHALOPATHY 47 0.0050
445 DISTURBANCE IN ATTENTION 271 0.0050
446 HYPOVOLAEMIC SHOCK 24 0.0050
447 GAMMA-GLUTAMYLTRANSFERASE INCREASED 110 0.0050
448 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 25 0.0049
449 TENSION 30 0.0049
450 MULTIPLE ORGAN DYSFUNCTION SYNDROME 139 0.0049
451 LETHARGY 282 0.0049
452 WHITE BLOOD CELL COUNT INCREASED 188 0.0049
453 BRAIN INJURY 49 0.0049
454 ASPARTATE AMINOTRANSFERASE INCREASED 259 0.0049
455 VENTRICULAR FIBRILLATION 54 0.0049
456 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
457 PULSELESS ELECTRICAL ACTIVITY 20 0.0048
458 HEPATIC NECROSIS 18 0.0048
459 ATELECTASIS 46 0.0048
460 SUICIDAL IDEATION 431 0.0047
461 PROTHROMBIN TIME PROLONGED 28 0.0047
462 NEUROTOXICITY 82 0.0047
463 INTRACRANIAL PRESSURE INCREASED 26 0.0047
464 HAEMODIALYSIS 39 0.0046
465 DIPLOPIA 120 0.0046
466 EXPOSURE DURING PREGNANCY 286 0.0046
467 THERAPY NON-RESPONDER 205 0.0046
468 SINUS BRADYCARDIA 44 0.0045
469 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
470 LOW BIRTH WEIGHT BABY 36 0.0045
471 URINARY INCONTINENCE 134 0.0045
472 CIRCULATORY COLLAPSE 77 0.0045
473 HYPERPHAGIA 18 0.0045
474 EPSTEIN-BARR VIRUS INFECTION 28 0.0045
475 OVERDOSE 955 0.0044
476 THROMBOTIC MICROANGIOPATHY 43 0.0044
477 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
478 BLOOD LACTATE DEHYDROGENASE INCREASED 68 0.0043
479 MULTI-ORGAN FAILURE 74 0.0043
480 HYPERPYREXIA 18 0.0042
481 ALANINE AMINOTRANSFERASE INCREASED 261 0.0042
482 ELECTROLYTE IMBALANCE 49 0.0042
483 APHASIA 127 0.0042
484 GESTATIONAL DIABETES 20 0.0042
485 CEREBRAL DISORDER 31 0.0042
486 LARGE INTESTINE PERFORATION 29 0.0042
487 CARDIAC MURMUR 36 0.0042
488 TREMOR 690 0.0042
489 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 71 0.0041
490 CAESAREAN SECTION 48 0.0041
491 TACHYCARDIA 366 0.0041
492 INGUINAL HERNIA 25 0.0041
493 PURPURA 36 0.0041
494 ANURIA 35 0.0041
495 GALACTORRHOEA 26 0.0040
496 SMALL FOR DATES BABY 20 0.0040
497 TRICUSPID VALVE INCOMPETENCE 32 0.0040
498 OLIGURIA 25 0.0040
499 PANCYTOPENIA 225 0.0040
500 HYDRONEPHROSIS 30 0.0040
501 RESPIRATORY DISTRESS 110 0.0040
502 C-REACTIVE PROTEIN INCREASED 145 0.0040
503 HEPATIC STEATOSIS 74 0.0040
504 ORTHOSTATIC HYPOTENSION 69 0.0040
505 FAECAL INCONTINENCE 19 0.0040
506 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
507 HYPOXIA 139 0.0039
508 ECCHYMOSIS 27 0.0039
509 ABORTION INDUCED 37 0.0039
510 BRADYCARDIA 207 0.0039
511 OSTEOPENIA 59 0.0039
512 DERMATITIS BULLOUS 28 0.0039
513 RESPIRATORY FAILURE 282 0.0039
514 NO THERAPEUTIC RESPONSE 47 0.0039
515 DISEASE RECURRENCE 182 0.0038
516 SUBSTANCE ABUSE 31 0.0038
517 PANCREATITIS 201 0.0038
518 DERMATITIS EXFOLIATIVE 19 0.0038
519 MATERNAL EXPOSURE DURING PREGNANCY 337 0.0038
520 TOXIC SKIN ERUPTION 38 0.0038
521 KLEBSIELLA INFECTION 19 0.0038
522 TUBULOINTERSTITIAL NEPHRITIS 70 0.0037
523 EOSINOPHIL COUNT INCREASED 31 0.0037
524 CONFUSIONAL STATE 599 0.0037
525 THINKING ABNORMAL 69 0.0037
526 HYPOTHYROIDISM 118 0.0037
527 NEUTROPENIA 502 0.0037
528 CYANOSIS 58 0.0037
529 PERICARDIAL EFFUSION 85 0.0037
530 LIVER INJURY 90 0.0037
531 BLOOD ALKALINE PHOSPHATASE INCREASED 91 0.0037
532 FAILURE TO THRIVE 19 0.0037
533 SUPRAVENTRICULAR TACHYCARDIA 35 0.0037
534 DEPRESSED MOOD 193 0.0036
535 HEPATIC ENZYME ABNORMAL 18 0.0036
536 INCONTINENCE 38 0.0036
537 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 255 0.0036
538 DRUG ABUSE 298 0.0036
539 HYPOTENSION 718 0.0036
540 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
541 POLYURIA 29 0.0035
542 CONDITION AGGRAVATED 1076 0.0035
543 CEREBRAL ISCHAEMIA 18 0.0035
544 PRODUCT USE IN UNAPPROVED INDICATION 859 0.0035
545 PETECHIAE 36 0.0034
546 APLASTIC ANAEMIA 18 0.0034
547 ERYTHEMA MULTIFORME 32 0.0034
548 COLITIS ISCHAEMIC 23 0.0034
549 LIPASE INCREASED 26 0.0034
550 MOOD ALTERED 92 0.0034
551 DECREASED ACTIVITY 36 0.0033
552 BLEPHAROSPASM 21 0.0033
553 ASPHYXIA 27 0.0033
554 FOETAL GROWTH RESTRICTION 20 0.0033
555 PREMATURE BABY 99 0.0033
556 LEFT VENTRICULAR DYSFUNCTION 22 0.0033
557 LUNG INFILTRATION 29 0.0033
558 HAEMATOCRIT DECREASED 65 0.0033
559 HYPERLIPIDAEMIA 39 0.0033
560 TARDIVE DYSKINESIA 92 0.0033
561 DERMATITIS ALLERGIC 41 0.0033
562 ACUTE RESPIRATORY DISTRESS SYNDROME 57 0.0032
563 PLEURISY 19 0.0032
564 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
565 HYPERSOMNIA 91 0.0032
566 HEPATITIS 81 0.0032
567 PHOTOPSIA 20 0.0032
568 SLEEP DISORDER 222 0.0031
569 HEPATIC FUNCTION ABNORMAL 116 0.0031
570 LIVE BIRTH 26 0.0031
571 HYPERBILIRUBINAEMIA 32 0.0031
572 LACTIC ACIDOSIS 100 0.0031
573 LYMPHOCYTE COUNT DECREASED 54 0.0031
574 ENERGY INCREASED 18 0.0030
575 RESPIRATION ABNORMAL 21 0.0030
576 DEMENTIA 85 0.0030
577 MUSCLE TWITCHING 70 0.0030
578 VENTRICULAR TACHYCARDIA 50 0.0030
579 ARRHYTHMIA 143 0.0030
580 OBSESSIVE-COMPULSIVE DISORDER 24 0.0030
581 HYPOGLYCAEMIA 145 0.0030
582 ACUTE RESPIRATORY FAILURE 57 0.0030
583 DIABETIC KETOACIDOSIS 71 0.0030
584 HEMIPARESIS 50 0.0029
585 INTERNATIONAL NORMALISED RATIO INCREASED 84 0.0029
586 DECUBITUS ULCER 24 0.0029
587 INTESTINAL PERFORATION 33 0.0029
588 RED BLOOD CELL COUNT DECREASED 84 0.0029
589 DRUG ERUPTION 52 0.0029
590 POLYNEUROPATHY 35 0.0029
591 DRUG INEFFECTIVE 3836 0.0029
592 HEMIPLEGIA 24 0.0029
593 MENTAL DISORDER 125 0.0029
594 DISSOCIATION 22 0.0029
595 CARDIOGENIC SHOCK 41 0.0029
596 GAIT DISTURBANCE 546 0.0028
597 WITHDRAWAL SYNDROME 119 0.0028
598 BLADDER DISORDER 28 0.0028
599 INCREASED APPETITE 53 0.0028
600 HYPOKALAEMIA 128 0.0028
601 TYPE 2 DIABETES MELLITUS 93 0.0028
602 SUBARACHNOID HAEMORRHAGE 28 0.0027
603 HYPERGLYCAEMIA 100 0.0027
604 HYPOMAGNESAEMIA 38 0.0027
605 FACE OEDEMA 46 0.0027
606 NEUTROPHIL COUNT DECREASED 111 0.0027
607 WEIGHT INCREASED 608 0.0027
608 URINARY RETENTION 90 0.0027
609 LOSS OF CONSCIOUSNESS 345 0.0027
610 BLOOD UREA INCREASED 45 0.0027
611 OXYGEN SATURATION DECREASED 151 0.0027
612 COELIAC DISEASE 26 0.0026
613 MITRAL VALVE INCOMPETENCE 30 0.0026
614 BODY TEMPERATURE INCREASED 54 0.0026
615 PALLOR 72 0.0026
616 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
617 PROTEINURIA 50 0.0026
618 SEPTIC SHOCK 114 0.0026
619 SLEEP APNOEA SYNDROME 50 0.0026
620 VENTRICULAR EXTRASYSTOLES 27 0.0026
621 HYPERCHOLESTEROLAEMIA 25 0.0026
622 INTENTIONAL DRUG MISUSE 54 0.0026
623 PREMATURE DELIVERY 41 0.0026
624 NERVOUS SYSTEM DISORDER 80 0.0026
625 SPLENOMEGALY 30 0.0026
626 PYREXIA 886 0.0026
627 HICCUPS 21 0.0026
628 OFF LABEL USE 2208 0.0025
629 HEPATIC CYTOLYSIS 32 0.0025
630 POOR QUALITY SLEEP 54 0.0025
631 PERICARDITIS 42 0.0025
632 DYSPHAGIA 236 0.0025
633 ANGER 84 0.0025
634 PLEURAL EFFUSION 151 0.0025
635 LIVER FUNCTION TEST ABNORMAL 72 0.0025
636 HEPATOCELLULAR INJURY 35 0.0025
637 HALLUCINATION 186 0.0025
638 MOUTH HAEMORRHAGE 18 0.0025
639 PSEUDOMONAS INFECTION 21 0.0024
640 GENERAL PHYSICAL HEALTH DETERIORATION 283 0.0024
641 CRYING 88 0.0024
642 BALANCE DISORDER 209 0.0024
643 MALNUTRITION 27 0.0024
644 HEPATIC ENZYME INCREASED 164 0.0024
645 ACCIDENTAL OVERDOSE 88 0.0024
646 BLOOD DISORDER 19 0.0024
647 PRESCRIBED UNDERDOSE 47 0.0024
648 BLOOD SODIUM DECREASED 44 0.0023
649 ATRIOVENTRICULAR BLOCK 18 0.0023
650 FEEDING DISORDER 47 0.0023
651 MYOPATHY 20 0.0023
652 CHOKING 45 0.0023
653 PLATELET COUNT INCREASED 30 0.0023
654 SEPSIS 256 0.0023
655 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
656 RED BLOOD CELL SEDIMENTATION RATE INCREASED 25 0.0023
657 ERECTILE DYSFUNCTION 58 0.0023
658 FEAR 60 0.0022
659 MOOD SWINGS 71 0.0022
660 BLOOD POTASSIUM INCREASED 36 0.0022
661 BONE MARROW FAILURE 45 0.0022
662 MOVEMENT DISORDER 71 0.0022
663 HYPERKALAEMIA 77 0.0022
664 INTENTIONAL PRODUCT MISUSE 192 0.0022
665 CHOLESTASIS 42 0.0022
666 JOINT DISLOCATION 23 0.0022
667 UROSEPSIS 20 0.0022
668 PARALYSIS 31 0.0022
669 VITAMIN D DEFICIENCY 21 0.0022
670 PNEUMONIA 690 0.0021
671 BEDRIDDEN 28 0.0021
672 CYTOPENIA 26 0.0021
673 LEUKAEMIA 20 0.0021
674 LOSS OF LIBIDO 19 0.0021
675 HYPOPHAGIA 54 0.0021
676 WHITE BLOOD CELL COUNT DECREASED 227 0.0021
677 DRUG INTOLERANCE 202 0.0021
678 HEAD INJURY 66 0.0021
679 PRODUCT USE ISSUE 391 0.0021
680 BLOOD BILIRUBIN INCREASED 56 0.0021
681 ABSCESS 33 0.0021
682 ANXIETY 587 0.0021
683 LYMPHADENOPATHY 73 0.0021
684 PULMONARY CONGESTION 27 0.0020
685 PREGNANCY 41 0.0020
686 BLOOD TRIGLYCERIDES INCREASED 36 0.0020
687 BODY TEMPERATURE DECREASED 20 0.0020
688 CARDIOMYOPATHY 30 0.0020
689 PRODUCT ADMINISTRATION ERROR 41 0.0020
690 SUBDURAL HAEMATOMA 29 0.0020
691 MYOCARDIAL ISCHAEMIA 23 0.0020
692 EATING DISORDER 43 0.0020
693 ARTERIOSCLEROSIS 19 0.0020
694 CARDIOTOXICITY 18 0.0020
695 RENAL FAILURE ACUTE 85 0.0020
696 MEDICATION ERROR 111 0.0020
697 THERAPEUTIC RESPONSE DECREASED 120 0.0020
698 PRODUCT PRESCRIBING ERROR 47 0.0020
699 PLATELET COUNT DECREASED 210 0.0020
700 SKIN INFECTION 22 0.0020
701 BRAIN NEOPLASM 18 0.0020
702 PERSONALITY CHANGE 18 0.0019
703 ACUTE KIDNEY INJURY 295 0.0019
704 HAEMOGLOBIN DECREASED 197 0.0019
705 CONTRAINDICATED PRODUCT ADMINISTERED 58 0.0019
706 MEMORY IMPAIRMENT 262 0.0019
707 HAEMATOMA 49 0.0019
708 BLOOD CREATININE INCREASED 122 0.0019
709 HEAD DISCOMFORT 33 0.0019
710 SLUGGISHNESS 19 0.0019
711 PULMONARY OEDEMA 83 0.0019
712 RESPIRATORY DISORDER 55 0.0018
713 CONJUNCTIVITIS 34 0.0018
714 AMENORRHOEA 32 0.0018
715 LIVER FUNCTION TEST INCREASED 39 0.0018
716 RESTLESS LEGS SYNDROME 33 0.0018
717 INSOMNIA 480 0.0018
718 SKIN LESION 49 0.0018
719 JOINT INJURY 38 0.0018
720 DECREASED APPETITE 413 0.0018
721 CANDIDA INFECTION 30 0.0018
722 LYMPHOPENIA 25 0.0018
723 MOUTH ULCERATION 37 0.0018
724 FALL 580 0.0017
725 POOR VENOUS ACCESS 18 0.0017
726 RASH GENERALISED 45 0.0017
727 MYELODYSPLASTIC SYNDROME 25 0.0017
728 EMOTIONAL DISORDER 53 0.0017
729 JAUNDICE 46 0.0017
730 MUSCULOSKELETAL STIFFNESS 148 0.0017
731 DEAFNESS 44 0.0017
732 CENTRAL NERVOUS SYSTEM LESION 23 0.0017
733 QUALITY OF LIFE DECREASED 22 0.0016
734 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
735 ABNORMAL WEIGHT GAIN 20 0.0016
736 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
737 DIABETES MELLITUS 123 0.0016
738 HAEMORRHAGE INTRACRANIAL 24 0.0016
739 OEDEMA 87 0.0016
740 BLOOD CALCIUM DECREASED 18 0.0016
741 BLOOD PRESSURE SYSTOLIC INCREASED 31 0.0016
742 FRACTURE 30 0.0016
743 ADVERSE REACTION 21 0.0016
744 ABDOMINAL DISTENSION 165 0.0016
745 MICTURITION URGENCY 18 0.0016
746 RESPIRATORY TRACT INFECTION 41 0.0016
747 NERVOUSNESS 82 0.0016
748 MIGRAINE 149 0.0016
749 LIVER DISORDER 69 0.0016
750 INTENTIONAL PRODUCT USE ISSUE 135 0.0015
751 HAEMATEMESIS 39 0.0015
752 VOMITING 720 0.0015
753 SECRETION DISCHARGE 19 0.0015
754 ACTIVITIES OF DAILY LIVING IMPAIRED 30 0.0015
755 UPPER RESPIRATORY TRACT INFECTION 70 0.0015
756 HYPERHIDROSIS 195 0.0015
757 ISCHAEMIC STROKE 27 0.0015
758 DEHYDRATION 196 0.0015
759 DISABILITY 29 0.0015
760 VERTIGO 89 0.0015
761 HYPERCALCAEMIA 18 0.0015
762 STAPHYLOCOCCAL INFECTION 48 0.0015
763 BACTERIAL INFECTION 27 0.0014
764 BLOOD PRESSURE DECREASED 96 0.0014
765 SYNCOPE 144 0.0014
766 ADVERSE DRUG REACTION 129 0.0014
767 CEREBRAL INFARCTION 35 0.0014
768 RASH ERYTHEMATOUS 68 0.0014
769 FEMUR FRACTURE 44 0.0014
770 BLISTER 79 0.0014
771 HYPERTENSION 296 0.0014
772 ANOREXIA 18 0.0014
773 CEREBRAL HAEMORRHAGE 50 0.0014
774 DRUG WITHDRAWAL SYNDROME 121 0.0014
775 PRODUCT SUBSTITUTION ISSUE 79 0.0014
776 DEEP VEIN THROMBOSIS 89 0.0014
777 MUSCULAR WEAKNESS 155 0.0014
778 ABDOMINAL PAIN 315 0.0014
779 AMNESIA 88 0.0014
780 WEIGHT DECREASED 374 0.0013
781 EYE DISORDER 44 0.0013
782 GASTROENTERITIS VIRAL 24 0.0013
783 GINGIVAL BLEEDING 18 0.0013
784 GASTROENTERITIS 19 0.0013
785 DISEASE PROGRESSION 154 0.0013
786 RENAL FAILURE 172 0.0013
787 RENAL IMPAIRMENT 108 0.0013
788 CONSTIPATION 279 0.0013
789 EAR INFECTION 33 0.0012
790 DRUG EFFECT INCOMPLETE 45 0.0012
791 HAEMATURIA 42 0.0012
792 URINARY TRACT INFECTION 207 0.0012
793 VIRAL INFECTION 40 0.0012
794 SENSORY DISTURBANCE 19 0.0012
795 ANHEDONIA 31 0.0012
796 DEVICE RELATED INFECTION 18 0.0012
797 INFECTION 169 0.0012
798 SKIN ULCER 30 0.0012
799 ANAEMIA 221 0.0012
800 EJECTION FRACTION DECREASED 18 0.0012
801 INTESTINAL OBSTRUCTION 43 0.0011
802 HERNIA 22 0.0011
803 GAIT INABILITY 38 0.0011
804 BLOOD CHOLESTEROL INCREASED 53 0.0011
805 HOSPITALISATION 174 0.0011
806 ANGIOEDEMA 50 0.0011
807 HEART RATE INCREASED 111 0.0011
808 THIRST 20 0.0011
809 THERAPEUTIC RESPONSE UNEXPECTED 50 0.0011
810 UNDERDOSE 81 0.0011
811 NECK PAIN 62 0.0011
812 CARDIAC FAILURE 89 0.0011
813 GASTRITIS 29 0.0011
814 POST PROCEDURAL COMPLICATION 21 0.0011
815 PHOTOSENSITIVITY REACTION 18 0.0011
816 DYSURIA 40 0.0011
817 RASH 473 0.0011
818 DIZZINESS 535 0.0011
819 MUCOSAL INFLAMMATION 28 0.0011
820 ABDOMINAL PAIN LOWER 27 0.0011
821 PHOTOPHOBIA 20 0.0011
822 OEDEMA PERIPHERAL 129 0.0011
823 VISUAL ACUITY REDUCED 35 0.0011
824 FEELING JITTERY 20 0.0010
825 ASTHENIA 394 0.0010
826 PANIC ATTACK 38 0.0010
827 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
828 RASH MACULAR 36 0.0010
829 NEPHROLITHIASIS 47 0.0010
830 ABASIA 25 0.0010
831 VISION BLURRED 138 0.0010
832 BLOOD POTASSIUM DECREASED 30 0.0010
833 ATRIAL FIBRILLATION 97 0.0010
834 BONE DISORDER 18 0.0010
835 COLITIS 37 0.0010
836 CHOLELITHIASIS 32 0.0010
837 MOBILITY DECREASED 70 0.0010
838 GYNAECOMASTIA 30 0.0010
839 PRODUCT AVAILABILITY ISSUE 22 0.0010
840 PRODUCT PRESCRIBING ISSUE 21 0.0010
841 FREQUENT BOWEL MOVEMENTS 26 0.0010
842 PULMONARY EMBOLISM 91 0.0010
843 CELLULITIS 48 0.0010
844 ACUTE MYOCARDIAL INFARCTION 28 0.0009
845 FOOT FRACTURE 18 0.0009
846 FATIGUE 719 0.0009
847 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
848 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
849 THERAPEUTIC PRODUCT EFFECT DECREASED 41 0.0009
850 PULMONARY HYPERTENSION 19 0.0009
851 ROAD TRAFFIC ACCIDENT 38 0.0009
852 PRESYNCOPE 22 0.0009
853 SKIN DISORDER 30 0.0009
854 INFLUENZA LIKE ILLNESS 74 0.0009
855 LUNG DISORDER 44 0.0009
856 GASTROINTESTINAL DISORDER 80 0.0009
857 MULTIPLE SCLEROSIS 42 0.0009
858 OSTEOPOROSIS 36 0.0009
859 DRY MOUTH 71 0.0009
860 NIGHTMARE 30 0.0009
861 FIBROMYALGIA 21 0.0009
862 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
863 ASCITES 25 0.0008
864 RASH PAPULAR 19 0.0008
865 DRUG ADMINISTRATION ERROR 26 0.0008
866 ALOPECIA 166 0.0008
867 FEBRILE NEUTROPENIA 56 0.0008
868 HEART RATE IRREGULAR 19 0.0008
869 DYSPEPSIA 82 0.0008
870 HAEMORRHAGE 87 0.0008
871 MALAISE 363 0.0008
872 INJURY 58 0.0008
873 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
874 CHILLS 95 0.0008
875 STOMATITIS 49 0.0008
876 DYSSTASIA 23 0.0008
877 DISCOMFORT 48 0.0008
878 NEURALGIA 19 0.0008
879 BLOOD GLUCOSE DECREASED 37 0.0008
880 NAUSEA 608 0.0008
881 DIARRHOEA 492 0.0008
882 SKIN DISCOLOURATION 35 0.0008
883 INFLAMMATION 39 0.0008
884 VISUAL IMPAIRMENT 93 0.0007
885 INFLUENZA 83 0.0007
886 INTENTIONAL DOSE OMISSION 21 0.0007
887 EPISTAXIS 55 0.0007
888 ADVERSE EVENT 67 0.0007
889 CYSTITIS 23 0.0007
890 LIP SWELLING 24 0.0007
891 DEATH 620 0.0007
892 HAEMOPTYSIS 20 0.0007
893 DRUG DEPENDENCE 113 0.0007
894 DYSPHONIA 41 0.0007
895 HEADACHE 437 0.0007
896 PRODUCTIVE COUGH 33 0.0007
897 BLINDNESS 28 0.0007
898 FEELING ABNORMAL 163 0.0007
899 SWELLING FACE 44 0.0007
900 ILLNESS 69 0.0007
901 DRUG EFFECT DECREASED 36 0.0007
902 MUSCULOSKELETAL PAIN 35 0.0007
903 HYPERSENSITIVITY 123 0.0007
904 PNEUMONITIS 18 0.0007
905 UNEVALUABLE EVENT 50 0.0007
906 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
907 CHRONIC KIDNEY DISEASE 50 0.0007
908 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
909 MYALGIA 111 0.0007
910 CEREBROVASCULAR ACCIDENT 110 0.0006
911 PALPITATIONS 76 0.0006
912 POLLAKIURIA 27 0.0006
913 BONE DENSITY DECREASED 20 0.0006
914 DYSPNOEA EXERTIONAL 24 0.0006
915 CONTUSION 61 0.0006
916 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23 0.0006
917 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
918 DYSPNOEA 350 0.0006
919 EYE SWELLING 23 0.0006
920 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
921 MUSCLE SPASMS 112 0.0006
922 CHEST PAIN 113 0.0006
923 IMPAIRED HEALING 20 0.0006
924 ILL-DEFINED DISORDER 37 0.0006
925 RASH PRURITIC 33 0.0006
926 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
927 TINNITUS 27 0.0006
928 COVID-19 103 0.0006
929 COUGH 164 0.0006
930 ERYTHEMA 119 0.0006
931 BLOOD PRESSURE INCREASED 88 0.0006
932 BLOOD GLUCOSE INCREASED 108 0.0006
933 ABDOMINAL PAIN UPPER 117 0.0006
934 HAEMATOCHEZIA 31 0.0006
935 ABDOMINAL DISCOMFORT 93 0.0006
936 GASTRIC DISORDER 19 0.0006
937 PRODUCT DOSE OMISSION ISSUE 161 0.0005
938 PARAESTHESIA 86 0.0005
939 OROPHARYNGEAL PAIN 50 0.0005
940 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
941 BRONCHITIS 39 0.0005
942 THERAPY CESSATION 27 0.0005
943 INCORRECT DOSE ADMINISTERED 120 0.0005
944 BACK PAIN 121 0.0005
945 THERAPY INTERRUPTED 37 0.0005
946 BONE PAIN 30 0.0005
947 PAIN 310 0.0005
948 FLATULENCE 28 0.0005
949 RENAL DISORDER 23 0.0005
950 BURNING SENSATION 34 0.0005
951 SWELLING 45 0.0005
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
953 EXTRA DOSE ADMINISTERED 19 0.0005
954 ASTHMA 53 0.0005
955 HYPOAESTHESIA 70 0.0005
956 CARDIAC DISORDER 43 0.0005
957 WHEEZING 27 0.0005
958 PRODUCT DOSE OMISSION 29 0.0004
959 EYE PAIN 25 0.0004
960 OCULAR HYPERAEMIA 21 0.0004
961 NO ADVERSE EVENT 80 0.0004
962 ECZEMA 23 0.0004
963 NASOPHARYNGITIS 81 0.0004
964 PRURITUS 167 0.0004
965 PAIN IN EXTREMITY 128 0.0004
966 INTERSTITIAL LUNG DISEASE 21 0.0004
967 OSTEOARTHRITIS 18 0.0004
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82 0.0004
969 FLUSHING 41 0.0004
970 NEUROPATHY PERIPHERAL 38 0.0004
971 INFUSION RELATED REACTION 26 0.0004
972 NASAL CONGESTION 23 0.0004
973 ANAPHYLACTIC REACTION 21 0.0004
974 SKIN EXFOLIATION 32 0.0004
975 FEELING HOT 23 0.0004
976 CATARACT 22 0.0004
977 RHINORRHOEA 23 0.0004
978 EMOTIONAL DISTRESS 42 0.0003
979 PERIPHERAL SWELLING 53 0.0003
980 CHEST DISCOMFORT 35 0.0003
981 URTICARIA 57 0.0003
982 MYOCARDIAL INFARCTION 56 0.0003
983 ACNE 23 0.0003
984 PSORIASIS 39 0.0003
985 DRUG DOSE OMISSION 49 0.0003
986 PRODUCT QUALITY ISSUE 40 0.0003
987 SINUSITIS 30 0.0003
988 JOINT SWELLING 34 0.0003
989 ARTHRALGIA 116 0.0003
990 CARDIAC FAILURE CONGESTIVE 21 0.0003
991 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
992 DRY SKIN 21 0.0002
993 INJECTION SITE PAIN 31 0.0001